Researchers say findings suggest it may be possible to stop cancer growth using approaches such as restraining TE activity in ...

Isomorphic Labs says it is advancing drug design programs across multiple therapeutic areas and drug modalities. These ...

The discussion covered emerging biologics, AI applications, and a strategy for supporting biomanufacturing in the current political climate.

The sudden departure of Peter Marks, MD, from the FDA has prompted a chorus of criticism and despair from industry leaders and trade organizations.

Qfitlia (fitusiran), an siRNA drug to treat the frequency of bleeding episodes in adult and pediatric patients with hemophilia A or B, gets FDA approval.

Researchers say they are exploring therapeutic options to block fatty acid accumulation and immunosuppressive signals between ...

Officials at ARM, ASGCT, and ISCT convened a small group of scientists, policy experts, religious leaders and patient ...

With President Donald Trump expected to levy tariffs on pharmaceuticals manufactured outside the United States, industry ...

A pair of privately-held developers of editing-based therapies have some successes to show for their recent efforts to ...

Researchers identified how a brain circuit involving dopamine and GLP-1 receptor impact palatability and hedonic eating.

Study found that reduced neurotensin in obese mice prevented dopamine from triggering the usual pleasure response to ...

CRISPR leaders came together to celebrate the one-year anniversary of the Danaher-IGI Beacon for CRISPR Cures collaboration, ...